Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia;Adjuvante topische Therapie mit einem Cannabinoid-Rezeptor-Agonisten bei postzosterischer Neuralgie im Gesicht

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 2, 2010, Pages 88-91

  Phan, Ngoc Quan ^a   Siepmann, Dorothee ^a   Gralow, Ingrid ^a   Ständer, Sonja ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Nociception; Pain; Palmitoylethanolamine; Pruritus; Zoster

Indexed keywords

CANNABINOID RECEPTOR AGONIST; PALMIDROL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; POSTHERPETIC NEURALGIA; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANALGESICS; FACE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; NOCICEPTORS; PAIN MEASUREMENT; PALMITIC ACIDS; RECEPTORS, CANNABINOID;

EID: 76149112934     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07213.x     Document Type: Article

References (26)

1. Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother 2004 5 : 551 559.
2. Rowblotham MC. Postherpetic neuralgia. Seminar in Neurology 1994 14 : 247 254.
3. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997 81 : 255 262.
4. Baron R, Jänig W. Neuropathische Schmerzen. In : Zenz M, Jurna I : Lehrbuch der Schmerztherapie, Wiss. Verl.-Ges. Stuttgart, 2001 : 475 484.
5. Ständer S, Schmelz M. Chronic itch and pain-similarities and differences. Eur J Pain 2006 10 : 473 478.
6. Ständer S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neuro-physiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003 139 : 1463 1470.
7. Oaklander AL, Bowsher D, Galer B, Haanpää M, Jensen M P. Herpes zoster itch: preliminary epidemiologic data. J Pain 2003 4 : 338 343.
8. AWMF Leitlinie : Zoster und Zosterschmerzen. 2002. AWMF-Leitlinien- Register Nr. 013/023.
9. Wassilew S W. Zosterneuralgien. J Dtsch Dermatol Ges 2006 4 : 871 881.
10. Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev 2007 18 : CD004846.
11. Reimann S, Luger TA, Metze D. Topische Anwendung von Capsaicin in der Dermatologie zur Therapie von Juckreiz und Schmerz, Hautarzt 2000 51 : 164 172.
12. Watson C P, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993 15 : 510 526.
13. LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D. The search for the palmioylethanolamide receptor. Life Sci 2005 77 : 1685 1698.
14. Ständer S, Schmelz M, Metze D, Luger T, Rukwied R. Distribution of cannabi-noid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 2005 38 : 177 188.
15. Richardson JD, Kilo S, Hargreaves KM. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 1998 75 : 111 119.
16. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998 394 : 277 281.
17. Kress M, Kuner R. Mode of action of cannabinoids on nociceptive nerve endings. Exp Brain Res 2009 196 : 79 88.
18. Guindon J, LoVerme J, Piomelli D, Beaulieu P. The antinoceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors. Anesth Analg 2007 104 : 1563 1569. (Pubitemid 46791304)
19. Rukwied R, Watkinson A, McGlone F, Dvorak M. Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain 2003 102 : 283 288. (Pubitemid 36369307)
20. Dvorak M, Watkinson A, McGlone F, Rukwied R. Histamine-induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 2003 52 : 238 245.
21. Johanek LM, Simone DA. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by heat injury. Pain 2004 109 : 432 442.
22. LaBuda CJ, Koblish M, Little PJ. Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain. Eur J Pharmacol 2005 527 : 172 174.
23. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodovra A, Davar G, Makriyannis A, Vanderah TW, Mata H P, Malan TP Jr. CB2 cannabinoid receptor activation produces antinoception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 2005 102 : 3093 3098.
24. Ständer S, Reinhardt HW, Luger TA. Topische Cannabinoidagonisten. Eine effektive, neue Möglichkeit zur Behandlung von chronischem Pruritus. Hautarzt 2006 57 : 801 807.
25. Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 2007 7 : 1581 1595.
26. Harden RN. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist 2005 11 : 111 122.